Evidence map›Paper›PMID 41652425›Full record

SynthesisBMC pulmonary medicine2026

Burden of chronic obstructive pulmonary disease among Indian adults: systematic review and meta‑analysis.

Pritam Halder, Ravindra Khaiwal, Sonu Goel, Nikhil Kumar, Madhura Sarkar, Manya Soni, Baridalyne Nongkynrih, Manish Chandra Prabhakar, Anshul Mamgai, Shivani Rathor

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pritam HalderDepartment of Community Medicine and School of Public Health, PGIMER, Chandigarh, 160012, India. rynedann@gmail.com.ORCID http://orcid.org/0009-0008-2407-6807
Ravindra KhaiwalDepartment of Community Medicine and School of Public Health, PGIMER, Chandigarh, 160012, India.
Sonu GoelDepartment of Community Medicine and School of Public Health, PGIMER, Chandigarh, 160012, India.
Nikhil KumarDepartment of Community Medicine and School of Public Health, PGIMER, Chandigarh, 160012, India.
Madhura SarkarDepartment of Community Medicine and School of Public Health, PGIMER, Chandigarh, 160012, India.
Manya SoniDepartment of Community Medicine and School of Public Health, PGIMER, Chandigarh, 160012, India.
Baridalyne NongkynrihCentre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.
Manish Chandra PrabhakarDepartment of Community Medicine and School of Public Health, PGIMER, Chandigarh, 160012, India.
Anshul MamgaiDepartment of Community Medicine and School of Public Health, PGIMER, Chandigarh, 160012, India.
Shivani RathorPGIMER, Chandigarh, 160012, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic Obstructive Pulmonary Disease (COPD) is a long-standing respiratory illness marked by ongoing airflow obstruction and inflammation. It continues to be a major contributor to global disease, and death, with low- and middle-income countries (LMICs) experiencing a disproportionate impact. India, as one of the largest LMICs, plays a significant role in global COPD-related mortality and disability-adjusted life years (DALYs). In India, COPD continues to be underrecognized owing to limited spirometry availability, inconsistent diagnostic approaches, and weak surveillance systems. Previous prevalence estimates are both outdated and methodologically inconsistent, while the COVID-19 pandemic may have further shifted disease trends. This systematic review and meta-analysis seeks to bridge these gaps by delivering current, standardized, and comprehensive prevalence data.

objectiveTo estimate the pooled prevalence of spirometry-confirmed COPD among Indian adults and identify key demographic and environmental correlates through a systematic review and meta-analysis of observational studies.

methodsThis systematic review and meta-analysis aimed to determine the prevalence of spirometry-confirmed COPD among Indian adults. The study was registered in PROSPERO (CRD420251140678) and conducted in accordance with PRISMA guidelines. Literature searches were carried out in PubMed, EMBASE, Scopus, and Web of Science up to June 9, 2025, using relevant MeSH terms and keywords on COPD, prevalence, and India. Eligible studies included observational designs reporting spirometry-based COPD prevalence in adults; studies relying on non-spirometry diagnosis, qualitative designs, interventions, or non-English publications were excluded. Three reviewers independently screened records, extracted study and population data, and evaluated methodological quality using the Joanna Briggs Institute (JBI) checklist. Pooled prevalence was calculated using a random-effects model. Heterogeneity was assessed with I2 and Cochran’s Q, complemented by Baujat and Galbraith plots. Subgroup and sensitivity analyses examined variations by diagnostic criteria, demographics, and exposures, while publication bias was tested using funnel plots, Egger’s and Begg’s methods, and trim-and-fill analysis.

resultsTwenty-three studies comprising 27,319 Indian adults were included. The pooled prevalence of COPD was 13% (95% CI: 9%–18%), with substantial heterogeneity (I2 = 99.8%). Higher prevalence was observed among smokers (37%), elderly adults (≥ 60 years: 27%), males (16%), and biomass fuel users (8%). Studies using GOLD criteria reported a higher prevalence (15%) than those using FEV₁/FVC < LLN (10%). Hospital-based studies showed a greater prevalence (27%) than community-based ones (12%). Regional variation was notable, with North India reporting the highest prevalence (19%) and West India the lowest (7%). Sensitivity analyses confirmed the robustness of findings; publication bias was minimal and did not significantly affect pooled estimates.

conclusionCOPD remains a significant and underrecognized public health challenge in India. As all included studies were appraised as good quality using the JBI tool, the evidence base is strong and supports reliable pooled estimates. Therefore, our conclusions emphasize the importance of routine spirometry-based screening, targeted interventions for high-risk groups, and integration of COPD surveillance into India’s NCD framework, while reinforcing gender-sensitive strategies and clean fuel initiatives as evidence-based measures to reduce disease burden and guide policy planning.

Indexed as

Cost of IllnessPulmonary Disease, Chronic ObstructiveAdultHumansIndiaPrevalenceSpirometryBiomassChronic Obstructive Pulmonary DiseaseCOPDGOLDIndiaLLNPrevalenceSpirometryTobacco

Identifiers

PMID41652425
PMCPMC12977579

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.